Pay in 4 interest-free payments of $27.50 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38
intermediate trophoblasts and villous stromal cells) is seen in all gestations that contain maternal genetic material
Previous studies have reported that PTK7 functions as a co-receptor in the semaphorin/plexin signaling pathway
(2022) Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy
Ligand-mediated Activation and Interaction with Vesicular Integral Membrane Protein 36
FITC Mouse Anti-Human CD19 Antibody (S-1039-46) Isotype control Sacituzumab govitecan (IMMU-132) is anProduct Specification Host Mouse Antigen CD19 Synonyms B lymphocyte antigen CD19, LE CD19, B lymphocyte surface antigen B4, Differentiation antigen CD19, T cell surface antigen Leu 12 Immunogen Recombinant Protein Location Cell membrane Accession P15391 Clone Number S 1039 46 Antibody Type Mouse mAb Isotype IgG1,k Application FCM Reactivity Hu Purification Protein G Concentration 0. 2mg ml Conjugation FITC Physical Appearance Liquid Storage Buffer